Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MDK | P21741 | 4/20 | 0.49 |
| ▸ | FGF1 | P05230 | 1/20 | 0.44 |
| ▸ | FGF2 | P09038 | 1/20 | 0.44 |
| ▸ | VEGFA | P15692 | 1/20 | 0.44 |
| ▸ | HPSE | Q9Y251 | 1/20 | 0.44 |
| ▸ | CAPN1 | P07384 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | SERPINC1 | P01008 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | PLCD1 | P51178 | 1/20 | 0.36 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.35 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.35 |
| ▸ | CNR1 | P21554 | 2/20 | 0.35 |
| ▸ | F10 | P00742 | 1/20 | 0.35 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.34 |
| ▸ | F2 | P00734 | 1/20 | 0.34 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14363910 | 1.00 | MDK (0.49) | MDKFGF1FGF2VEGFAHPSE | |
| SCHEMBL13039112 | 1.00 | MDK (0.49) | MDKFGF1FGF2VEGFAHPSE | |
| SCHEMBL13039111 | 1.00 | MDK (0.49) | MDKFGF1FGF2VEGFAHPSE | |
| SCHEMBL12606413 | 0.97 | MDK (0.49) | MDKFGF1FGF2VEGFAHPSE | |
| SCHEMBL12606419 | 0.97 | MDK (0.49) | MDKFGF1FGF2VEGFAHPSE | |
| SCHEMBL12606415 | 0.94 | MDK (0.46) | MDKFGF1FGF2VEGFAHPSE | |
| SCHEMBL29435448 | 0.88 | MDK (0.53) | MDKFGF1FGF2VEGFAHPSE | |
| SCHEMBL12606406 | 0.81 | FGF1 (0.43) | MDKFGF1FGF2VEGFAHPSE | |
| SCHEMBL12606407 | 0.80 | FGF1 (0.42) | MDKFGF1FGF2VEGFAHPSE | |
| SCHEMBL12606400 | 0.79 | FGF1 (0.40) | MDKFGF1FGF2VEGFAHPSE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070270342-A1 | BIOTINYLATED HEXADECASACCHARIDES, PREPARATION AND USE THEREOF | SANOFI-AVENTIS (FR) | 2007-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070270342-A1 | BIOTINYLATED HEXADECASACCHARIDES, PREPARATION AND USE THEREOF | BTD, OSTC, HEXB | MDK 4606/4885FGF1 2950/4885FGF2 2308/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.